Document is current
Any future updates will be listed below
-
Authors
Isbell, Lisa K
Uibeleisen, Roswitha
Friedl, Alexander
Burger, Elvira
Dopatka, Tatja
Scherer, Florian
Orban, Andras
Lauer, Eliza
Malenica, Natalie
Semenova, Inna
Vreden, Annika
Valk, Elke
Wendler, Julia
Neumaier, Simone
Fricker, Heidi
El Rabih, Abed Al Hadi
Gloggengießer, Cora
Hilbig, Daniela
Bleul, Sabine
Weis, Joachim
Gmehlin, Dennis
Backenstrass, Matthias
Wirtz, Sebastian
Ihorst, Gabriele
Finke, Jürgen
Illerhaus, Gerald
Schorb, Elisabeth
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 29 June 2023
Accepted: 19 July 2023
First Online: 18 August 2023
Declarations
:
: The trial was developped in accordance with relevant guidelines and regulations such as the Declaration of Helsinki. The trial protocol was approved by the leading ethics committee (Ethik-Kommission Albert-Ludwigs-Universität Freiburg, ethics approval number 22-1513-AMG-ff multi and the local ethics committees. Written informed consent for trial participation has been/will be obtained from all participants and/or their legal guardians before entering the PRIMA-CNS trial. Recruitment will start in the 2nd or 3rd quarter 2023.Participating trial centers are:In Germany: Universitätsklinikum Aachen, Universitätsklinikum Augsburg, Charité - Universitätsmedizin Berlin, Helios Klinikum Berlin-Buch, Evangelisches Klinikum Bethel Bielefeld, Städtisches Klinikum Braunschweig, Klinikum Bremen, Universitätsklinikum Knappschaftskrankenhaus Bochum, Klinikum Chemnitz, Universitätsklinikum Dresden, Universitätsklinikum Düsseldorf, Universitätsklinikum Erlangen, Universitätsklinikum Essen, Universitätsklinikum Frankfurt, Universitätsklinikum Freiburg, Universitätsmedizin Göttingen, Universitätsklinikum Halle, Universitätsklinikum Heidelberg, St Vincentius Krankenhaus Heidelberg, Universitätsklinikum Homburg, Städtisches Klinikum Karlsruhe, Universitätsklinikum Schleswig-Holstein Kiel and Lübeck, Gemeinschaftsklinikum Mittelrhein gGmbH Koblenz, Universitätsklinikum Köln, Universitätsklinikum Leipzig, Munic –TU, Uniklinik Münster, Universitätsklinik Nürnberg, Klinikum Oldenburg, Pius Hospital Oldenburg, Universitätsklinikum Regensburg, Universitätsmedizin Rostock, Klinikum Stuttgart, Universitätsklinikum Tübingen, Universitätsklinikum Ulm, Klinikum Villingen-Schwenningen.In Austria: Kepler Universitätsklinikum Linz, Hanusch Hospital Vienna, Universitätsklinikum Graz.
: Not applicable.
: ES and GI received speakers’ honoraria and research funding from Riemser Pharma GmbH. GI received research funding from Roche Pharma AG and AbbVie, outside the submitted work. All other authors declare no conflict of interest.
